A detailed history of Squarepoint Ops LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 168,324 shares of EXEL stock, worth $5.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
168,324
Previous 89,449 88.18%
Holding current value
$5.6 Million
Previous $2.01 Million 117.42%
% of portfolio
0.01%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.96 - $27.6 $1.73 Million - $2.18 Million
78,875 Added 88.18%
168,324 $4.37 Million
Q2 2024

Aug 14, 2024

BUY
$20.34 - $23.73 $1.29 Million - $1.5 Million
63,352 Added 242.76%
89,449 $2.01 Million
Q1 2024

May 15, 2024

SELL
$20.17 - $23.93 $368,465 - $437,153
-18,268 Reduced 41.18%
26,097 $619,000
Q4 2023

Feb 14, 2024

SELL
$19.25 - $24.13 $198,737 - $249,118
-10,324 Reduced 18.88%
44,365 $1.06 Million
Q2 2023

Aug 14, 2023

BUY
$18.17 - $20.48 $993,699 - $1.12 Million
54,689 New
54,689 $1.05 Million
Q4 2022

Feb 14, 2023

BUY
$14.96 - $17.39 $333,593 - $387,779
22,299 New
22,299 $357,000
Q2 2022

Aug 15, 2022

SELL
$17.44 - $23.16 $1.39 Million - $1.84 Million
-79,619 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$17.03 - $22.67 $356,795 - $474,959
-20,951 Reduced 20.83%
79,619 $1.81 Million
Q4 2021

Feb 14, 2022

SELL
$15.84 - $21.88 $4.1 Million - $5.67 Million
-259,142 Reduced 72.04%
100,570 $1.84 Million
Q3 2021

Nov 15, 2021

BUY
$16.3 - $21.14 $1.44 Million - $1.87 Million
88,635 Added 32.7%
359,712 $7.6 Million
Q2 2021

Aug 16, 2021

SELL
$17.95 - $25.56 $1.61 Million - $2.29 Million
-89,525 Reduced 24.83%
271,077 $4.94 Million
Q1 2021

May 17, 2021

BUY
$20.53 - $25.22 $5.33 Million - $6.55 Million
259,595 Added 257.01%
360,602 $8.15 Million
Q4 2020

Feb 16, 2021

BUY
$18.39 - $24.8 $772,012 - $1.04 Million
41,980 Added 71.12%
101,007 $2.03 Million
Q3 2020

Nov 16, 2020

SELL
$20.67 - $26.94 $6.92 Million - $9.02 Million
-334,997 Reduced 85.02%
59,027 $1.44 Million
Q2 2020

Aug 14, 2020

BUY
$16.46 - $27.42 $3.69 Million - $6.14 Million
223,980 Added 131.72%
394,024 $9.35 Million
Q1 2020

May 15, 2020

SELL
$14.46 - $21.8 $7.83 Million - $11.8 Million
-541,785 Reduced 76.11%
170,044 $2.93 Million
Q4 2019

Feb 14, 2020

BUY
$15.15 - $18.89 $6.15 Million - $7.67 Million
406,051 Added 132.79%
711,829 $12.5 Million
Q3 2019

Nov 14, 2019

BUY
$17.68 - $22.65 $3.44 Million - $4.4 Million
194,446 Added 174.65%
305,778 $5.41 Million
Q2 2019

Aug 14, 2019

BUY
$18.93 - $24.75 $2.11 Million - $2.76 Million
111,332 New
111,332 $2.38 Million
Q1 2019

May 15, 2019

SELL
$19.6 - $24.76 $1.52 Million - $1.92 Million
-77,356 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$13.65 - $21.8 $223,750 - $357,345
-16,392 Reduced 17.49%
77,356 $1.52 Million
Q3 2018

Nov 14, 2018

SELL
$15.87 - $22.4 $5.16 Million - $7.29 Million
-325,274 Reduced 77.63%
93,748 $1.66 Million
Q2 2018

Aug 14, 2018

BUY
$18.56 - $22.45 $5.41 Million - $6.54 Million
291,297 Added 228.07%
419,022 $9.02 Million
Q1 2018

May 15, 2018

SELL
$22.15 - $31.89 $3.22 Million - $4.63 Million
-145,277 Reduced 53.21%
127,725 $2.83 Million
Q4 2017

Feb 14, 2018

BUY
$24.23 - $30.93 $788,201 - $1.01 Million
32,530 Added 13.53%
273,002 $8.3 Million
Q3 2017

Nov 14, 2017

BUY
$23.35 - $29.24 $5.62 Million - $7.03 Million
240,472
240,472 $5.83 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.